logo

BLISSGVS vs KREBSBIO: Stock Comparison

BLISSGVS vs KREBS BIOCHEMICALS & INDUpdated 2 Jul 26, 4:08 PM ISTNSE & company filings

BLISSGVS is the larger company by market capitalisation. BLISSGVS shows a higher dividend yield, faster revenue growth and a higher ROCE, while KREBS BIOCHEMICALS & IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLISSGVS leads 7; KREBSBIO leads 2 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLISSGVSKREBSBIO

Valuation lens

What price are you paying?

Market CapContext only
₹6,808 Cr
₹125 Cr
P/E RatioKREBSBIO has the lower reading
49.75x
0x ✓
P/B RatioKREBSBIO has the lower reading
5.68x
0x ✓
EPSBLISSGVS has the higher reading
₹4.72 ✓
₹-1.15
Book ValueContext only
₹116.14
—
Dividend YieldBLISSGVS has the higher reading
0.25% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLISSGVS is the larger company
₹6,808 Cr vs ₹125 Cr
P/E Ratio
KREBSBIO has a lower P/E
0x vs 49.75x
P/B Ratio
KREBSBIO has a lower P/B
0x vs 5.68x
EPS
BLISSGVS has higher earnings per share
₹4.72 vs ₹-1.15
Dividend Yield
BLISSGVS has a higher dividend yield
0.25% vs 0%
Revenue Growth (TTM YoY)
BLISSGVS has faster revenue growth
29.8% vs 11.6%
EPS Growth (TTM YoY)
BLISSGVS has faster EPS growth
124.7% vs 0%
ROCE
BLISSGVS has a higher ROCE
9.22% vs -15.89%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLISSGVSKREBSBIO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricBLISSGVSKREBSBIO
Live Price₹527.1₹57.48
Day Change0.68%2.53%
Volume3.93 L3,570
52-Week High₹553₹76.85
52-Week Low₹118₹38.33
Distance from 52W High-4.68%-25.2%

Valuation

MetricBLISSGVSKREBSBIO
Market Cap₹6,808 Cr₹125 Cr
P/E Ratio49.75x0x
P/B Ratio5.68x0x
EPS₹4.72₹-1.15
Book Value₹116.14—
Dividend Yield0.25%0%

Growth

MetricBLISSGVSKREBSBIO
Revenue Growth (TTM YoY)29.8%11.6%
EPS Growth (TTM YoY)124.7%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricBLISSGVSKREBSBIO
ROE8.39%—
ROCE9.22%-15.89%
Net Margin13.93%-71.35%
Operating Margin19.81%-41.49%
Debt to Equity0x—

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBLISSGVSKREBSBIO
Promoter Holding35.01%▼ 0.35 pp72.74%
FII Holding8.07%▼ 2.38 pp0.5%
DII Holding9.47%▲ 4.43 pp0%
Public Holding47.45%▼ 1.7 pp26.76%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLISSGVS and KREBS BIOCHEMICALS & IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.